Ocular manifestations in a patient with de novo Fabry disease
You-Hyun LEE; Kyu-Young SHIM; Sung-Bae PARK; Yu-Cheol KIM; You-Hyun LEE; Kyu-Young SHIM; Sung-Bae PARK; Yu-Cheol KIM.
Yeungnam University Journal of Medicine
; : 232-235, 2018.
Artículo en Inglés | WPRIM | ID: wpr-787106
Documentos relacionados
[Clinical and morphological changes in the eye in Fabry's disease (a clinical case study)].
GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals.
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease.
Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease.
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease.
[Advances in the specific treatment of Fabry disease].
Corneal densitometry: a potential indicator for early diagnosis of Fabry disease.
[Clinical analysis of 10 patients with Fabry disease].
Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept.
Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.